Corpus Intelligence IC Memo — CPMC-R.K. DAVIES MEDICAL CENTER 2026-04-26 05:28 UTC
IC Memo — CPMC-R.K. DAVIES MEDICAL CENTER
Investment Committee Memorandum | CA | 105 beds | Grade C | EBITDA uplift $17.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CPMC-R.K. DAVIES MEDICAL CENTER

CCN 050008 | SAN FRANCISCO, CA | 105 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CPMC-R.K. DAVIES MEDICAL CENTER is a 105-bed suburban community hospital in SAN FRANCISCO, CA with $243.7M in net patient revenue and a 24.6% operating margin. The hospital serves a payer mix of 31.3% Medicare, 4.9% Medicaid, and 63.7% commercial.

Thesis: Turnaround. Our ML models identify $17.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 24.6% to 31.9% (+736bps).

Net Revenue HCRIS$243.7M
Current EBITDA COMPUTED$59.9M
Operating Margin COMPUTED24.6%
Occupancy HCRIS41.1%
Revenue / Bed COMPUTED$2.3M
Net-to-Gross HCRIS30.5%
Distress Probability ML49.0%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
171
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of 24.6% places it above the state median. Among 171 size-comparable peers (52-210 beds), the median margin is -4.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (52-210), prioritizing same-state peers. 171 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CPMC-R.K. DAVIES MEDICAL CENTE (Target)CA105$243.7M24.6%
CHILDRENS HOSP & RES CNTR OAKLCA155$687.9M-7.1%
NORTHBAY HOSPITAL GROUPCA204$676.6M-8.2%
CONTRA COSTA REGIONAL MEDICAL CA124$595.0M-29.2%
KFH - VALLEJOCA184$531.7M0.3%
RANCHO LOS AMIGOS NATL.REHAB.CCA83$512.6M41.9%
DOMINICAN HOSPITALCA202$499.0M5.0%
CMH OF SAN BUENAVENTURACA170$498.5M-7.6%
USC NORRIS CANCER HOSPITALCA60$468.7M19.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $17.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.1M+210bp18mo
Cost to Collect4.5%2.5%$4.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.0M+122bp9mo
Clean Claim Rate88.0%96.0%$156K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.1M
Cost to Collect
$4.9M
Denial Rate Reduction
$4.8M
A/R Days Reduction
$3.0M
Clean Claim Rate
$156K
Total EBITDA Uplift$17.9M
Current EBITDA$59.9M
+ RCM Uplift+$17.9M
Pro Forma EBITDA$77.8M
Current Margin24.6%
Pro Forma Margin31.9%
WC Released (1x)$9.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$92.1M$574.2M6.23x44.2%
Base (11x exit)10.0x11.0x$92.1M$661.6M7.18x48.3%
Bull Case9.0x11.0x$82.9M$750.7M9.06x55.4%
Bull (12x exit)9.0x12.0x$82.9M$843.4M10.17x59.0%
Bear Case11.0x10.0x$101.3M$454.7M4.49x35.0%
Bear (11x exit)11.0x11.0x$101.3M$533.0M5.26x39.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 171 hospitals with 52-210 beds
  • Same-state prioritization (n=172)
  • Comp margins: P25=-21.0% / P50=-4.7% / P75=3.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.